KRYS KRYSTAL BIOTECH INC
2026Q1 · CUSIP 501147102 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
365
Δ holders QoQ
+29
Breadth percentile
Top 10%
Whale holders
169
Δ whales
+9
Inst. holding value
$7.3B
New positions
75
Closed positions
46
Price momentum (1Q)
+1.4%
Put / Call
6/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 13 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 10% | — | — |
| 2025Q4 | Top 9% | +1.4% | — |
| 2025Q1 | Top 5% | +8.8% | +57.4% |
| 2024Q3 | Top 7% | +7.0% | -28.7% |
| 2024Q2 | Top 19% | -7.8% | -8.4% |
| 2024Q1 | Top 6% | +21.1% | +4.0% |
| 2023Q2 | Top 9% | -15.7% | -7.1% |
| 2022Q3 | Top 11% | +3.2% | +26.7% |
Options Sentiment
Put holders
6
QoQ: +2
Call holders
6
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
45.8
EPS (TTM)
$7.47
EPS YoY
+79.1%
Revenue (TTM)
$0.4B
Revenue YoY
+25.1%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)